T. Haeufel

Safety and tolerability of spesolimab in patients with ulcerative colitis

G. D'Haens, M. Ferrante, C. Selinger, 2022, Expert opinion on drug safety.

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

S. Walsh, K. Brown, K. Flaherty, 2019, The New England journal of medicine.

Assessment of the Pharmacokinetics and Safety of Spesolimab, a Humanised Anti-interleukin-36 Receptor Monoclonal Antibody, in Healthy Non-Japanese and Japanese Subjects: Results from Phase I Clinical Studies

X. Li, T. Haeufel, C. Thoma, 2022, Clinical pharmacokinetics.

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

M. Lebwohl, T. Tsai, D. Thaçi, 2023, The Lancet.